Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Professional Survey Report 2017

December 2017 | 115 pages | ID: G4F1EB8A042EN
QYResearch

Abstracts

This report studies B-Cell Maturation Antigen(BCMA) Targeted Therapies in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Transposagen Biopharmaceuticals
• Sutro Biopharma
• Malin Corporation
• Eureka Therapeutics
• firstVentury Equity
• Five Prime Therapeutics
• Credit Suisse Securities
• Dana-Farber Cancer Institute
• Deerfield Partners
• Onyx Pharmaceuticals
• Juno Therapeutics

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Bispecific Antibodies
• Antibody Drug Conjugates
• Chimeric Antigen Receptor T-Cells

By Application, the market can be split into

• Liver Cancer
• Respiratory Cancer
• Brain Cancer
• Others

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF B-CELL MATURATION ANTIGEN(BCMA) TARGETED THERAPIES

1.1 Definition and Specifications of B-Cell Maturation Antigen(BCMA) Targeted Therapies
  1.1.1 Definition of B-Cell Maturation Antigen(BCMA) Targeted Therapies
  1.1.2 Specifications of B-Cell Maturation Antigen(BCMA) Targeted Therapies
1.2 Classification of B-Cell Maturation Antigen(BCMA) Targeted Therapies
  1.2.1 Bispecific Antibodies
  1.2.2 Antibody Drug Conjugates
  1.2.3 Chimeric Antigen Receptor T-Cells
1.3 Applications of B-Cell Maturation Antigen(BCMA) Targeted Therapies
  1.3.1 Liver Cancer
  1.3.2 Respiratory Cancer
  1.3.3 Brain Cancer
  1.3.4 Others
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF B-CELL MATURATION ANTIGEN(BCMA) TARGETED THERAPIES

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of B-Cell Maturation Antigen(BCMA) Targeted Therapies
2.3 Manufacturing Process Analysis of B-Cell Maturation Antigen(BCMA) Targeted Therapies
2.4 Industry Chain Structure of B-Cell Maturation Antigen(BCMA) Targeted Therapies

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF B-CELL MATURATION ANTIGEN(BCMA) TARGETED THERAPIES

3.1 Capacity and Commercial Production Date of Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Major Manufacturers in 2016

4 GLOBAL B-CELL MATURATION ANTIGEN(BCMA) TARGETED THERAPIES OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Capacity and Growth Rate Analysis
  4.2.2 2016 B-Cell Maturation Antigen(BCMA) Targeted Therapies Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales and Growth Rate Analysis
  4.3.2 2016 B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Price
  4.4.2 2016 B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Price Analysis (Company Segment)

5 B-CELL MATURATION ANTIGEN(BCMA) TARGETED THERAPIES REGIONAL MARKET ANALYSIS

5.1 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Analysis
  5.1.1 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Overview
  5.1.2 North America 2012-2017E B-Cell Maturation Antigen(BCMA) Targeted Therapies Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Price Analysis
  5.1.4 North America 2016 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share Analysis
5.2 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Analysis
  5.2.1 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Overview
  5.2.2 China 2012-2017E B-Cell Maturation Antigen(BCMA) Targeted Therapies Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Price Analysis
  5.2.4 China 2016 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share Analysis
5.3 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Analysis
  5.3.1 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Overview
  5.3.2 Europe 2012-2017E B-Cell Maturation Antigen(BCMA) Targeted Therapies Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Price Analysis
  5.3.4 Europe 2016 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share Analysis
5.4 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Analysis
  5.4.1 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Overview
  5.4.2 Southeast Asia 2012-2017E B-Cell Maturation Antigen(BCMA) Targeted Therapies Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Price Analysis
  5.4.4 Southeast Asia 2016 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share Analysis
5.5 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Analysis
  5.5.1 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Overview
  5.5.2 Japan 2012-2017E B-Cell Maturation Antigen(BCMA) Targeted Therapies Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Price Analysis
  5.5.4 Japan 2016 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share Analysis
5.6 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Analysis
  5.6.1 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Overview
  5.6.2 India 2012-2017E B-Cell Maturation Antigen(BCMA) Targeted Therapies Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Price Analysis
  5.6.4 India 2016 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share Analysis

6 GLOBAL 2012-2017E B-CELL MATURATION ANTIGEN(BCMA) TARGETED THERAPIES SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales by Type
6.2 Different Types of B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Interview Price Analysis
6.3 Different Types of B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Driving Factors Analysis
  6.3.1 Bispecific Antibodies of B-Cell Maturation Antigen(BCMA) Targeted Therapies Growth Driving Factor Analysis
  6.3.2 Antibody Drug Conjugates of B-Cell Maturation Antigen(BCMA) Targeted Therapies Growth Driving Factor Analysis
  6.3.3 Chimeric Antigen Receptor T-Cells of B-Cell Maturation Antigen(BCMA) Targeted Therapies Growth Driving Factor Analysis

7 GLOBAL 2012-2017E B-CELL MATURATION ANTIGEN(BCMA) TARGETED THERAPIES SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption by Application
7.2 Different Application of B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Interview Price Analysis
7.3 Different Application of B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Driving Factors Analysis
  7.3.1 Liver Cancer of B-Cell Maturation Antigen(BCMA) Targeted Therapies Growth Driving Factor Analysis
  7.3.2 Respiratory Cancer of B-Cell Maturation Antigen(BCMA) Targeted Therapies Growth Driving Factor Analysis
  7.3.3 Brain Cancer of B-Cell Maturation Antigen(BCMA) Targeted Therapies Growth Driving Factor Analysis
  7.3.4 Others of B-Cell Maturation Antigen(BCMA) Targeted Therapies Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF B-CELL MATURATION ANTIGEN(BCMA) TARGETED THERAPIES

8.1 Transposagen Biopharmaceuticals
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Transposagen Biopharmaceuticals 2016 B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Transposagen Biopharmaceuticals 2016 B-Cell Maturation Antigen(BCMA) Targeted Therapies Business Region Distribution Analysis
8.2 Sutro Biopharma
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Sutro Biopharma 2016 B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Sutro Biopharma 2016 B-Cell Maturation Antigen(BCMA) Targeted Therapies Business Region Distribution Analysis
8.3 Malin Corporation
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Malin Corporation 2016 B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Malin Corporation 2016 B-Cell Maturation Antigen(BCMA) Targeted Therapies Business Region Distribution Analysis
8.4 Eureka Therapeutics
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Eureka Therapeutics 2016 B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Eureka Therapeutics 2016 B-Cell Maturation Antigen(BCMA) Targeted Therapies Business Region Distribution Analysis
8.5 firstVentury Equity
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 firstVentury Equity 2016 B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 firstVentury Equity 2016 B-Cell Maturation Antigen(BCMA) Targeted Therapies Business Region Distribution Analysis
8.6 Five Prime Therapeutics
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Five Prime Therapeutics 2016 B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Five Prime Therapeutics 2016 B-Cell Maturation Antigen(BCMA) Targeted Therapies Business Region Distribution Analysis
8.7 Credit Suisse Securities
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Credit Suisse Securities 2016 B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Credit Suisse Securities 2016 B-Cell Maturation Antigen(BCMA) Targeted Therapies Business Region Distribution Analysis
8.8 Dana-Farber Cancer Institute
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Dana-Farber Cancer Institute 2016 B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Dana-Farber Cancer Institute 2016 B-Cell Maturation Antigen(BCMA) Targeted Therapies Business Region Distribution Analysis
8.9 Deerfield Partners
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 Deerfield Partners 2016 B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Deerfield Partners 2016 B-Cell Maturation Antigen(BCMA) Targeted Therapies Business Region Distribution Analysis
8.10 Onyx Pharmaceuticals
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 Onyx Pharmaceuticals 2016 B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Onyx Pharmaceuticals 2016 B-Cell Maturation Antigen(BCMA) Targeted Therapies Business Region Distribution Analysis
8.11 Juno Therapeutics

9 DEVELOPMENT TREND OF ANALYSIS OF B-CELL MATURATION ANTIGEN(BCMA) TARGETED THERAPIES MARKET

9.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Trend Analysis
  9.1.1 Global 2017-2022 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Price Forecast
9.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Regional Market Trend
  9.2.1 North America 2017-2022 B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast
  9.2.2 China 2017-2022 B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast
  9.2.3 Europe 2017-2022 B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast
  9.2.5 Japan 2017-2022 B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast
  9.2.6 India 2017-2022 B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast
9.3 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Trend (Product Type)
9.4 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Trend (Application)

10 B-CELL MATURATION ANTIGEN(BCMA) TARGETED THERAPIES MARKETING TYPE ANALYSIS

10.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Regional Marketing Type Analysis
10.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of B-Cell Maturation Antigen(BCMA) Targeted Therapies by Region
10.4 B-Cell Maturation Antigen(BCMA) Targeted Therapies Supply Chain Analysis

11 CONSUMERS ANALYSIS OF B-CELL MATURATION ANTIGEN(BCMA) TARGETED THERAPIES

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL B-CELL MATURATION ANTIGEN(BCMA) TARGETED THERAPIES MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of B-Cell Maturation Antigen(BCMA) Targeted Therapies
Table Product Specifications of B-Cell Maturation Antigen(BCMA) Targeted Therapies
Table Classification of B-Cell Maturation Antigen(BCMA) Targeted Therapies
Figure Global Production Market Share of B-Cell Maturation Antigen(BCMA) Targeted Therapies by Type in 2016
Figure Bispecific Antibodies Picture
Table Major Manufacturers of Bispecific Antibodies
Figure Antibody Drug Conjugates Picture
Table Major Manufacturers of Antibody Drug Conjugates
Figure Chimeric Antigen Receptor T-Cells Picture
Table Major Manufacturers of Chimeric Antigen Receptor T-Cells
Table Applications of B-Cell Maturation Antigen(BCMA) Targeted Therapies
Figure Global Consumption Volume Market Share of B-Cell Maturation Antigen(BCMA) Targeted Therapies by Application in 2016
Figure Liver Cancer Examples
Table Major Consumers in Liver Cancer
Figure Respiratory Cancer Examples
Table Major Consumers in Respiratory Cancer
Figure Brain Cancer Examples
Table Major Consumers in Brain Cancer
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of B-Cell Maturation Antigen(BCMA) Targeted Therapies by Regions
Figure North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (Million USD) (2012-2022)
Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (Million USD) (2012-2022)
Figure Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (Million USD) (2012-2022)
Figure Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (Million USD) (2012-2022)
Figure Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (Million USD) (2012-2022)
Figure India B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (Million USD) (2012-2022)
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of B-Cell Maturation Antigen(BCMA) Targeted Therapies in 2016
Figure Manufacturing Process Analysis of B-Cell Maturation Antigen(BCMA) Targeted Therapies
Figure Industry Chain Structure of B-Cell Maturation Antigen(BCMA) Targeted Therapies
Table Capacity and Commercial Production Date of Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Major Manufacturers in 2016
Table R&D Status and Technology Source of Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of B-Cell Maturation Antigen(BCMA) Targeted Therapies 2012-2017
Figure Global 2012-2017E B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (Volume) and Growth Rate
Figure Global 2012-2017E B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (Value) and Growth Rate
Table 2012-2017E Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Capacity and Growth Rate
Table 2016 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Capacity (K Units) List (Company Segment)
Table 2012-2017E Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales (K Units) and Growth Rate
Table 2016 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales (K Units) List (Company Segment)
Table 2012-2017E Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Price (USD/Unit)
Table 2016 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of B-Cell Maturation Antigen(BCMA) Targeted Therapies 2012-2017E
Figure North America 2012-2017E B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Price (USD/Unit)
Figure North America 2016 B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of B-Cell Maturation Antigen(BCMA) Targeted Therapies 2012-2017E
Figure China 2012-2017E B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Price (USD/Unit)
Figure China 2016 B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of B-Cell Maturation Antigen(BCMA) Targeted Therapies 2012-2017E
Figure Europe 2012-2017E B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Price (USD/Unit)
Figure Europe 2016 B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of B-Cell Maturation Antigen(BCMA) Targeted Therapies 2012-2017E
Figure Southeast Asia 2012-2017E B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Price (USD/Unit)
Figure Southeast Asia 2016 B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of B-Cell Maturation Antigen(BCMA) Targeted Therapies 2012-2017E
Figure Japan 2012-2017E B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Price (USD/Unit)
Figure Japan 2016 B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of B-Cell Maturation Antigen(BCMA) Targeted Therapies 2012-2017E
Figure India 2012-2017E B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Price (USD/Unit)
Figure India 2016 B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share
Table Global 2012-2017E B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales (K Units) by Type
Table Different Types B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Interview Price
Table Global 2012-2017E B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales (K Units) by Application
Table Different Application B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Interview Price
Table Transposagen Biopharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2016 Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Business Region Distribution
Table Sutro Biopharma Information List
Table Product A Overview
Table Product B Overview
Table 2016 Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Business Region Distribution
Table Malin Corporation Information List
Table Product A Overview
Table Product B Overview
Table 2015 Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Business Region Distribution
Table Eureka Therapeutics Information List
Table Product A Overview
Table Product B Overview
Table 2016 Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Business Region Distribution
Table firstVentury Equity Information List
Table Product A Overview
Table Product B Overview
Table 2016 firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Business Region Distribution
Table Five Prime Therapeutics Information List
Table Product A Overview
Table Product B Overview
Table 2016 Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Business Region Distribution
Table Credit Suisse Securities Information List
Table Product A Overview
Table Product B Overview
Table 2016 Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Business Region Distribution
Table Dana-Farber Cancer Institute Information List
Table Product A Overview
Table Product B Overview
Table 2016 Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Business Region Distribution
Table Deerfield Partners Information List
Table Product A Overview
Table Product B Overview
Table 2016 Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Business Region Distribution
Table Onyx Pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2016 Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Business Region Distribution
Table Juno Therapeutics Information List
Figure Global 2017-2022 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (K Units) and Growth Rate Forecast
Figure Global 2017-2022 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Price (USD/Unit) Forecast
Figure North America 2017-2022 B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2017-2022 B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2017-2022 B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2017-2022 B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2017-2022 B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of B-Cell Maturation Antigen(BCMA) Targeted Therapies by Type 2017-2022
Table Global Consumption Volume (K Units) of B-Cell Maturation Antigen(BCMA) Targeted Therapies by Application 2017-2022
Table Traders or Distributors with Contact Information of B-Cell Maturation Antigen(BCMA) Targeted Therapies by Region